Cite
MLA Citation
Chiara Rosa Mancinelli et al.. “Switching to ocrelizumab in RRMS patients at risk of PML previously treated with extended interval dosing of natalizumab.” Multiple sclerosis, vol. 27, 2021, pp. 790–794. http://access.bl.uk/ark:/81055/vdc_100117864740.0x000033